Companies: 10,795·Total market cap: $144.5T
MicroVision, Inc.

MicroVision, Inc.

MVISNASDAQTechnology● Active
$0.39
$-0.00(-0.13%)
Market Cap$129329850
P/E Ratio
52W High$1.73
52W Low$0.38

MicroVision, Inc. (MVIS) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · MVIS · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$1.21M$4.70M$7.26M$0.66M$2.50M
Cost of Revenue$18.55M$7.53M$2.77M$0.10M$0.00M
Gross Profit($17.34M)($2.83M)$4.49M$0.56M$2.50M
Gross Margin %(computed)-60.35%61.81%84.94%99.92%
Operating Expenses
R&D Expenses$31.72M$49.02M$56.71M$30.41M$24.11M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$52.05M$82.69M$93.36M$54.45M$46.37M
Operating Income($69.39M)($85.52M)($88.88M)($53.89M)($43.87M)
Operating Margin %(computed)
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$18.53M$4.46M$0.08M$0.06M$0.00M
Income Before Tax($95.06M)($96.41M)($81.70M)($53.09M)($43.20M)
Income Tax Expense($0.08M)$0.51M$1.15M$0.00M$0.00M
Net Income($94.98M)($96.92M)($82.84M)($53.09M)($43.20M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.35$-0.46$-0.45$-0.32$-0.27
Wtd Avg Shares273.14M209.51M182.80M165.96M160.66M
EBITDA($63.56M)($70.98M)($83.07M)($53.15M)($42.92M)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M

Explore more MicroVision, Inc. data

About MicroVision, Inc. (MVIS) Income Statement

MicroVision, Inc. (MVIS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MVIS reported revenue of $0.00B, gross profit of ($0.02B) (gross margin -1435.43%), and net income of ($0.09B) — a net profit margin of -7862.67%.

Frequently asked questions

MVIS · 4 questions

MicroVision, Inc. (MVIS) reported revenue of $0.00B for 2025, down 74.3% year-over-year.

MVIS revenueMVIS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08